5,822
Views
135
CrossRef citations to date
0
Altmetric
ACTA ONCOLOGICA LECTURE

Preoperative staging of rectal cancer

&
Pages 20-31 | Received 15 Aug 2007, Published online: 08 Jul 2009

References

  • Dukes CE. The classification of cancer of the rectum. J Path Bact 1932; 35: 323–32
  • Astler VB, Coller FA. The prognostic significance of direct extension of carcinoma of the colon and rectum. Ann Surg 1954; 139: 846–52
  • Jass JR, Love SB, Northover JM. A new prognostic classification of rectal cancer. Lancet 1987; 1(8545)1303–6
  • Harrison JC, Dean PJ, el-Zeky F, Vander Zwaag R. From Dukes through Jass: Pathological prognostic indicators in rectal cancer [see comments]. Human Pathol 1994; 25: 498–505
  • Moertel CG, Fleming TR, MacDonald JS, Haller DG, Laurie JA, Tangen CM, et al. Fluorouracil plus levamisole as effective adjuvant therapy after resection of stage III colon carcinoma: A final report. Ann Intern Med 1995; 122: 321–6
  • Anonymous. Randomised trial of surgery alone versus surgery followed by radiotherapy for mobile cancer of the rectum. Medical Research Council Rectal Cancer Working Party [see comments]. Lancet 1996;348(9042):1610–4.
  • Krook JE, Moertel CG, Gunderson LL, et al. Effective surgical adjuvant therapy for high-risk rectal carcinoma. N Engl J Med 1991; 324: 709–15
  • Anonymous. Adjuvant radiotherapy for rectal cancer: A systematic overview of 8,507 patients from 22 randomised trials. Lancet 2001;358(9290):1291–304.
  • Anonymous. Improved survival with preoperative radiotherapy in resectable rectal cancer. Swedish Rectal Cancer Trial [see comments] [published erratum appears in N Engl J Med 1997 May 22;336(21):1539]. New Engl J Med 1997;336:980–7.
  • Sauer R, Becker H, Hohenberger W, Rodel C, Wittekind C, Fietkau R, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004; 351: 1731–40
  • Burton S, Brown G, Daniels I, Norman AR, Swift I, Abulafi AM, et al. MRI identified prognostic features of tumors in distal sigmoid, rectosigmoid, and upper rectum: Treatment with radiotherapy and chemotherapy. Int J Radiat Oncol Biol Phys 2006; 65: 445–51
  • Brown G, Daniels IR, Richardson C, Revell P, Peppercorn D, Bourne M. Techniques and trouble-shooting in high spatial resolution thin slice MRI for rectal cancer. Br J Radiol 2005; 78(927)245–51
  • Brown G, Richards CJ, Newcombe RG, Dallimore NS, Radcliffe AG, Carey DP, et al. Rectal carcinoma: Thinsection MR imaging for staging in 28 patients. Radiology 1999; 211: 215–22
  • Brown G, Kirkham A, Williams GT, Bourne M, Radcliffe AG, Sayman J, et al. High-resolution MRI of the anatomy important in total mesorectal excision of the rectum. AJR Am J Roentgenol 2004; 182: 431–9
  • Compton CC, Greene FL. The staging of colorectal cancer: 2004 and beyond. CA Cancer J Clin 2004; 54: 295–308
  • Sobin LH Wittekind C TNM Classification of Malignant Tumours (UICC). 6th ed. 2002.
  • Cawthorn SJ, Parums DV, Gibbs NM, A'Hern RP, Caffarey SM, Broughton CI, et al. Extent of mesorectal spread and involvement of lateral resection margin as prognostic factors after surgery for rectal cancer [see comments]. Lancet 1990; 335(8697)1055–9
  • Willett CG. Technical advances in the treatment of patients with rectal cancer [editorial; comment]. Inter J Radiat Oncol Biol Phys 1999;45:1107–8.
  • Brown G, Radcliffe AG, Newcombe RG, Dallimore NS, Bourne MW, Williams GT. Preoperative assessment of prognostic factors in rectal cancer using high-resolution magnetic resonance imaging. Br J Surg 2003; 90: 355–64
  • Low RN, McCue M, Barone R, Saleh F, Song T. MR staging of primary colorectal carcinoma: Comparison with surgical and histopathologic findings. Abdom Imaging 2003; 28: 784–93
  • Branagan G, Chave H, Fuller C, McGee S, Finnis D. Can magnetic resonance imaging predict circumferential margins and TNM stage in rectal cancer?. Dis Colon Rectum 2004; 47: 1317–22
  • Akasu T, Iinuma G, Fujita T, Muramatsu Y, Tateishi U, Miyakawa K, et al. Thin-section MRI with a phased-array coil for preoperative evaluation of pelvic anatomy and tumor extent in patients with rectal cancer. AJR Am J Roentgenol 2005; 184: 531–8
  • MERCURY Study Group. Extramural depth of tumor invasion at thin-section MR in patients with rectal cancer: Results of the MERCURY study. Radiology 2007;243:132–9.
  • Adam IJ, Mohamdee MO, Martin IG, Scott N, Finan PJ, Johnston D, et al. Role of circumferential margin involvement in the local recurrence of rectal cancer. Lancet 1994; 344(8924)707–11
  • Suzuki K, Muto T, Sawada T. Prevention of local recurrence by extended lymphadenectomy for rectal cancer. Surg Today 1995; 25: 795–801
  • Billingham RP. Extended lymphadenectomy for rectal cancer: Cure vs quality of life. Int Surg 1994; 79: 11–22
  • Moreira LF, Kenmotsu M, Gochi A, Tanaka N, Orita K. Lymphovascular and neural invasion in low-lying rectal carcinoma. Cancer Detect Prevent 1999; 23: 123–8
  • Brown G, Richards CJ, Bourne MW, Newcombe RG, Radcliffe AG, Dallimore NS, et al. Morphologic predictors of lymph node status in rectal cancer with use of highspatial-resolution MR imaging with histopathologic comparison. Radiology 2003; 227: 371–7
  • Gunther K, Dworak O, Remke S, Pfluger R, Merkel S, Hohenberger W, et al. Prediction of distant metastases after curative surgery for rectal cancer. J Surg Res 2002; 103: 68–78
  • Hildebrandt U, Klein T, Feifel G, Schwarz HP, Koch B, Schmitt RM. Endosonography of pararectal lymph nodes. In vitro and in vivo evaluation. Dis Colon Rectum 1990; 33: 863–8
  • Hildebrandt U, Feifel G. Importance of endoscopic ultrasonography staging for treatment of rectal cancer. Gastrointest Endosc Clin N Am 1995; 5: 843–9
  • Hulsmans FH, Bosma A, Mulder PJ, Reeders JW, Tytgat GN. Perirectal lymph nodes in rectal cancer: in vitro correlation of sonographic parameters and histopathologic findings. Radiology 1992; 184: 553–60
  • Schnall MD, Furth EE, Rosato EF, Kressel HY. Rectal tumor stage: Correlation of endorectal MR imaging and pathologic findings [see comments]. Radiology 1994; 190: 709–14
  • Koh DM, Brown G, Temple L, Raja A, Toomey P, Bett N, et al. Rectal cancer: Mesorectal lymph nodes at MR imaging with USPIO versus histopathologic findings–initial observations. Radiology 2004; 231: 91–9
  • Ueno H, Mochizuki H, Tamakuma S. Prognostic significance of extranodal microscopic foci discontinuous with primary lesion in rectal cancer. Dis Colon Rectum 1998; 41: 55–61
  • Singh AK, Myerson RJ, Birnbaum EH, Fleshman JW, Kodner IJ, Lockett MA, et al. Outcome of patients with rectal adenocarcinoma and localized pelvic non- nodal metastatic foci. Dis Colon Rectum 2000; 43: 1217–21
  • Quirke P, Durdey P, Dixon MF, Williams NS. Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumour spread and surgical excision. Lancet 1986; 2(8514)996–9
  • Hall NR, Finan PJ, al-Jaberi T, Tsang CS, Brown SR, Dixon MF, et al. Circumferential margin involvement after mesorectal excision of rectal cancer with curative intent. Predictor of survival but not local recurrence?. Dis Colon Rectum 1998; 41: 979–83
  • Birbeck KF, Macklin CP, Tiffin NJ, Parsons W, Dixon MF, Mapstone NP, et al. Rates of circumferential resection margin involvement vary between surgeons and predict outcomes in rectal cancer surgery. Ann Surg 2002; 235: 449–57
  • Heald RJ, Ryall RD. Recurrence and survival after total mesorectal excision for rectal cancer. Lancet 1986; 1(8496)1479–82
  • Kapiteijn E, Putter H, van de Velde CJ. Impact of the introduction and training of total mesorectal excision on recurrence and survival in rectal cancer in The Netherlands. Br J Surg 2002; 89: 1142–9
  • Bissett IP, Fernando CC, Hough DM, Cowan BR, Chau KY, Young AA, et al. Identification of the fascia propria by magnetic resonance imaging and its relevance to preoperative assessment of rectal cancer. Dis Colon Rectum 2001; 44: 259–65
  • Heald RJ, Husband EM, Ryall RD. The mesorectum in rectal cancer surgery--the clue to pelvic recurrence?. Br J Surg 1982; 69: 613–6
  • Heald RJ, Moran BJ, Ryall RD, Sexton R, MacFarlane JK. Rectal cancer: The Basingstoke experience of total mesorectal excision, 1978–1997. Arch Surg 1998; 133: 894–9
  • Reynolds JV, Joyce WP, Dolan J, Sheahan K, Hyland JM. Pathological evidence in support of total mesorectal excision in the management of rectal cancer. Br J Surg 1996; 83: 1112–5
  • Hermanek P. Impact of surgeon's technique on outcome after treatment of rectal carcinoma. Dis Colon Rectum 1999; 42: 559–62
  • Dixon AR, Maxwell WA, Holmes JT. Carcinoma of the rectum: A 10-year experience. Br J Surg 1991; 78: 308–11
  • Enker WE, Thaler HT, Cranor ML, Polyak T. Total mesorectal excision in the operative treatment of carcinoma of the rectum. J Am Coll Surg 1995; 181: 335–46
  • McCall JL, Cox MR, Wattchow DA. Analysis of local recurrence rates after surgery alone for rectal cancer. Int J Colorectal Dis 1995; 10: 126–32
  • Nesbakken A, Nygaard K, Westerheim O, Mala T, Lunde OC. Local recurrence after mesorectal excision for rectal cancer. Eur J Surg Oncol 2002; 28: 126–34
  • Martling AL, Holm T, Rutqvist LE, Moran BJ, Heald RJ, Cedemark B. Effect of a surgical training programme on outcome of rectal cancer in the County of Stockholm. Stockholm Colorectal Cancer Study Group, Basingstoke Bowel Cancer Research Project. Lancet 2000; 356(9224)93–6
  • Wibe A, Rendedal PR, Svensson E, Norstein J, Eide TJ, Myrvold HE, et al. Prognostic significance of the circumferential resection margin following total mesorectal excision for rectal cancer. Br J Surg 2002; 89: 327–34
  • Beets-Tan RG, Beets GL, Vliegen RF, Kessels AG, Van Boven H, De Bruine A, et al. Accuracy of magnetic resonance imaging in prediction of tumour-free resection margin in rectal cancer surgery. Lancet 2001; 357(9255)497–504
  • Purkayastha S, Tekkis PP, Athanasiou T, Tilney HS, Darzi AW, Heriot AG. Diagnostic precision of magnetic resonance imaging for preoperative prediction of the circumferential margin involvement in patients with rectal cancer. Colorectal Dis 2007; 9: 402–11
  • MERCURY Study Group. Diagnostic accuracy of preoperative magnetic resonance imaging in predicting curative resection of rectal cancer: Prospective observational study. BMJ 2006;333(7572):779.
  • Talbot IC, Ritchie S, Leighton MH, Hughes AO, Bussey HJ, Morson BC. The clinical significance of invasion of veins in cancer of the rectum. Br J Surg 1980; 67: 439–42
  • Talbot IC, Ritchie S, Leighton M, Hughes AO, Bussey HJ, Morson BC. Invasion of veins by carcinoma of rectum: Method of detection, histological features and significance. Histopathology 1981; 5: 141–63
  • Talbot IC, Ritchie S, Leighton MH, Hughes AO, Bussey HJ, Morson BC. Spread of rectal cancer within veins. Histologic features and clinical significance. Am J Surg 1981; 141: 15–7
  • Tsuchiya A, Ando Y, Kikuchi Y, Kanazawa M, Sato H, Abe R. Venous invasion as a prognostic factor in colorectal cancer. Surg Today 1995; 25: 950–3
  • Lui KK, Enjoji M, Inokuchi K. Venous permeation of colorectal carcinoma. Jap J Surg 1980; 10: 284–9
  • Sunderland D. The significance of vein invasion by cancer of the rectum and sigmoid: A microscopic study of 210 cases. Cancer 1949; 2: 429–37
  • Krasna MJ, Flancbaum L, Cody RP, Shneibaum S, Ben Ari G. Vascular and neural invasion in colorectal carcinoma. Incidence and prognostic significance. Cancer 1988; 61: 1018–23
  • Minsky BD, Mies C, Recht A, Rich TA, Chaffey JT. Resectable adenocarcinoma of the rectosigmoid and rectum. II. The influence of blood vessel invasion. Cancer 1988; 61: 1417–24
  • Rich T, Gunderson LL, Lew R, Galdibini JJ, Cohen AM, Donaldson G. Patterns of recurrence of rectal cancer after potentially curative surgery. Cancer 1983; 52: 1317–29
  • Knudsen JB, Nilsson T, Sprechler M, Johansen A, Christensen N. Venous and nerve invasion as prognostic factors in postoperative survival of patients with resectable cancer of the rectum. Dis Colon Rectum 1983; 26: 613–7
  • Bokey EL, Ojerskog B, Chapuis P, Dent O, Newland RC, Sinclair G. Local recurrence after curative excision of the rectum for cancer without adjuvant therapy: Role of total anatomical dissection. Br J Surg 1999; 86: 1164–70
  • Ouchi K, Sugawara T, Ono H, Fujiya T, Kamiyama Y, Kakugawa Y, et al. Histologic features and clinical significance of venous invasion in colorectal carcinoma with hepatic metastasis. Cancer 1996; 78: 2313–7
  • Shirouzu K, Isomoto H, Kakegawa T, Morimatsu M. A prospective clinicopathologic study of venous invasion in colorectal cancer. Am J Surg 1991; 162: 216–22
  • Horn A, Dahl O, Morild I. Venous and neural invasion as predictors of recurrence in rectal adenocarcinoma. Dis Colon Rectum 1991; 34: 798–804
  • Chapuis PH, Dent OF, Fisher R, Newland RC, Pheils MT, Smyth E, et al. A multivariate analysis of clinical and pathological variables in prognosis after resection of large bowel cancer. Br J Surg 1985; 72: 698–702
  • Freedman LS, Macaskill P, Smith AN. Multivariate analysis of prognostic factors for operable rectal cancer. Lancet 1984; 2(8405)733–6
  • Horn A, Dahl O, Morild I. The role of venous and neural invasion on survival in rectal adenocarcinoma. Dis Colon Rectum 1990; 33: 598–601
  • Mulcahy HE, Toner M, Patchett SE, Daly L, O'Donoghue DP. Identifying stage B colorectal cancer patients at high risk of tumor recurrence and death. Dis Colon Rectum 1997; 40: 326–31
  • Newland R, Dent O, Lyttle M, Chapuis P, Bokey E. Pathological determinants of survival associated with colorectal cancer with lymph node metastases. Cancer 1994; 73: 2076–82
  • Smith NJ, Barbachano Y, Norman AR, Swift RI, Abulafi AM, Brown G. Prognostic significance of magnetic resonance imaging-detected extramural vascular invasion in rectal cancer. Br J Surg 2007 (in press).
  • Brown G, Daniels IR. Preoperative staging of rectal cancer: The MERCURY research project. Recent Results Cancer Res 2005; 165: 58–74
  • Burton S, Brown G, Daniels IR, Norman AR, Mason B, Cunningham D. MRI directed multidisciplinary team preoperative treatment strategy: The way to eliminate positive circumferential margins?. Br J Cancer 2006; 94: 351–7
  • Glimelius B. Rectal cancer irradiation. Long course, short course or something else?. Acta Oncol 2006; 45: 1013–7
  • Chau I, Brown G, Cunningham D, Tait D, Wotherspoon A, Norman AR, et al. Neoadjuvant capecitabine and oxaliplatin followed by synchronous chemoradiation and total mesorectal excision in magnetic resonance imaging-defined poorrisk rectal cancer. J Clin Oncol 2006; 24: 668–74

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.